Cutaneous toxicity with suprabasal blisters and dyskeratosis following administration of enfortumab vedotin

被引：4

作者：

Hasui, Ken-Ichi ^{[1
,3
]}

Kawakami, Yoshio ^{[1
]}

Miyake, Tomoko ^{[1
]}

Hirai, Yoji ^{[1
]}

Nomura, Hayato

Edamura, Kohei ^{[2
]}

Araki, Motoo ^{[2
]}

Morizane, Shin ^{[1
]}

机构：

[1] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Dermatol, Okayama, Japan

[2] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Urol, Okayama, Japan

[3] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Dermatol, 2-5-1 Shikata Cho,Kita Ku, Okayama, Okayama 7008558, Japan

来源：

JOURNAL OF DERMATOLOGY | 2023年 / 50卷 / 04期

关键词：

D O I：

10.1111/1346-8138.16646

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：E115 / E116

页数：2

共 5 条

[1]

Dobry Allison S, 2021, JAAD Case Rep, V14, P7, DOI [10.1016/j.jdcr.2021.05.020, 10.1016/j.jdcr.2021.05.020]

[2] Nectin-4 Mutations Causing Ectodermal Dysplasia with Syndactyly Perturb the Rac1 Pathway and the Kinetics of Adherens Junction Formation [J].

Fortugno, Paola ;

Josselin, Emmanuelle ;

Tsiakas, Konstantinos ;

Agolini, Emanuele ;

Cestra, Gianluca ;

Teson, Massimo ;

Santer, Rene ;

Castiglia, Daniele ;

Novelli, Giuseppe ;

Dallapiccola, Bruno ;

Kurth, Ingo ;

Lopez, Marc ;

Zambruno, Giovanna ;

Brancati, Francesco .

JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2014, 134 (08) :2146-2153

[3] Enfortumab vedotin-induced cutaneous adverse events manifesting as miliaria-like eruptions with the presence of keratinocyte apoptosis in clinically intact skin [J].

Oya, K. ;

Nakamura, Y. ;

Iwamoto, K. ;

Kimura, T. ;

Negoro, H. ;

Nishiyama, H. ;

Fujisawa, Y. .

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2022, 36 (12) :E1009-E1011

[4] Clinical and direct immunofluorescence characteristics of cutaneous toxicity associated with enfortumab vedotin [J].

Penny, Caitlin L. ;

Quow, Krystina ;

Rundle, Chandler W. ;

Al-Rohil, Rami N. ;

Cardones, Adela R. ;

Kheterpal, Meenal K. ;

Fresco, Amber I. .

BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 (01) :126-127

[5] Cutaneous Toxicity Associated With Enfortumab Vedotin: A Real-Word Study Leveraging US Food and Drug Administration Adverse Event Reporting System [J].

Yang, Hui ;

Yu, Xiaojia ;

An, Zhuoling .

FRONTIERS IN ONCOLOGY, 2022, 11

← 1 →